First Peer-Reviewed Coronavirus Vaccine Trial Shows Promising Results in Mice

'We had previous experience on SARS-CoV in 2003 and MERS-CoV in 2014,' said Andrea Gambotto, co-senior author of the peer-reviewed paper published in the journal EBioMedicine, and associate professor of surgery at the Pittsburgh School of Medicine, in a statement. 'These two viruses, which are closely related to SARS-CoV–2, teach us that a particular protein, called a spike protein, is important for inducing immunity against the virus,' Gambotto explained. 'We knew exactly where to fight this new virus.'